북미의 병원용 가운 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the north america hospital gowns market size is expected to increase from USD 1.47 billion in 2025 to USD 1.57 billion in 2026 and reach USD 2.12 billion by 2031, growing at a CAGR of 6.22% over 2026-2031.

This report is Segmented by Usability (Disposable Gowns, Reusable Gowns), Type (Surgical Gowns, Non-Surgical Gowns, Patient Gowns), Risk Type (Minimal, Low, Moderate, High Risk), End User (Hospitals and Clinics, Long-Term Care, Ambulatory Surgical Centers, Home Healthcare), and Country (United States, Canada, Mexico). The Market Forecasts are Provided in Terms of Value (USD).

North America Hospital Gowns Market Trends and Insights

Infection Control Mandates and Hospital-Acquired Infection Prevention

Infection control rules continue to set the base demand pattern for the North America hospital gowns market, because facilities still need compliant protective apparel across acute care, post-acute settings, and long-term care environments. CDC reporting cited by CIDRAP showed that 1 in 31 hospitalized patients had at least 1 healthcare-associated infection on any given day in 2024, which keeps prevention spending tied to routine care practice rather than temporary outbreak response. Lower rates for CLABSI, CAUTI, and hospital-onset C. difficile did not reduce the need for gowns, because those gains depended on consistent infection-control behavior and continued PPE discipline at the point of care. CDC Enhanced Barrier Precautions also extended gown-and-glove use for high-contact activities in nursing homes, which widened the use case beyond acute care hospitals and made utilization more routine in skilled nursing settings. That broader care footprint matters because gowns are no longer tied only to operating rooms or isolation episodes, they are also tied to everyday resident handling and direct-contact care tasks in facilities with vulnerable patients. The result is a demand floor that stays firm even when individual infection indicators improve, because the health systems that perform better are usually the ones that keep protective routines in place rather than easing them.

Surgical Volume Growth and Procedural Throughput Requirements

Surgical throughput remains a direct growth engine for the North America hospital gowns market, especially as more procedures move into ambulatory settings that need dependable supply and rapid replenishment. MedPAC reported that ambulatory surgical center volume per 1,000 Medicare fee-for-service beneficiaries rose 3.4% in 2024, which confirms that outpatient procedural demand kept moving higher and continued to shift case volume beyond the hospital setting. This matters for gown demand because ASCs usually run tighter inventories and faster room turnover, which raises the value of ready-to-use stock, simple SKU planning, and dependable delivery cadence. It also changes channel economics, since many outpatient sites operate outside the large centralized procurement structures that define purchasing in major hospital systems. Vendors that can support premium barrier protection, responsive restocking, and a smaller-site service model are better positioned as procedural mix keeps changing across the region. What looks like a volume shift is also a distribution shift, and that gives suppliers with flexible fulfillment a clearer timing advantage in the North America hospital gowns market.

Premium Product Cost Pressure in Budget-Constrained Facilities

Cost pressure still limits how far the North America hospital gowns market can move into premium products across every care setting, especially where infection-control needs must be balanced against fixed operating budgets. Safety-net hospitals, critical access sites, and public facilities with constrained supply spending are more likely to favor lower-cost tiers when higher-barrier gowns carry a visible price premium over standard alternatives. That pressure becomes stronger under bundled and value-based payment models, because administrators are pushed to manage supply cost per encounter without disrupting clinical throughput or compliance. Hybrid purchasing is therefore becoming more common, with reusable products used for routine care and disposable products reserved for surgery or higher-risk isolation use. This approach protects clinical standards, but it can reduce unit demand for premium single-use gowns in facilities that are actively reviewing every line item in their textile budgets. The result is a slower upgrade cycle in budget-sensitive accounts, even when clinicians recognize the operational benefits of better barrier protection and more specialized gown formats.

Other drivers and restraints analyzed in the detailed report include:

1. Rising Preference for Disposable Gowns in High-Turnover Care Settings
2. Sustainability-Led Reusable Gown Procurement in Mature Health Systems
3. Supply Chain Dependence on Nonwoven and Meltblown Inputs

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Disposable gowns held 71.31% of North America hospital gowns market share in 2025, which reflected their entrenched role in surgical, isolation, and fast-turnover care environments where immediate availability remains a clinical expectation. Their lead was structural rather than temporary, because many infection-prevention protocols and day-to-day hospital workflows still favor single-use assurance when contact intensity is high and turnaround windows are short. This position is reinforced in emergency care, operating rooms, and outpatient sites that do not want added complexity from collection, sorting, or reprocessing steps between encounters. It is also reinforced by the regulatory culture around barrier validation, where facilities often prefer products with straightforward deployment and consistent unit-level performance. As a result, disposable volume remains deeply rooted across the North America hospital gowns industry even as procurement teams put more pressure on waste reduction and lifecycle cost.

Reusable gowns are forecast to expand at 8.38% CAGR through 2031, which makes them the faster-moving usability segment in the North America hospital gowns market as sustainability and cost-per-use logic gain wider acceptance. The growth case is strongest where health systems can support laundry validation, return logistics, and garment tracking without increasing operational burden for frontline staff. Island Health's 2025 reusable gown program showed that these requirements can be managed inside a working care network while maintaining infection-control standards and consistent textile handling practices. Adoption is not moving fastest in complex surgical settings, because those environments carry more fluid-management demands and stricter barrier-performance expectations over prolonged procedures. It is moving faster in routine patient care, isolation corridors, and long-term care environments where gowns are changed often and the cumulative waste from disposables is easier to measure. This is why reusable programs are increasingly framed as operational systems rather than textile substitutions, because their economics depend on service design as much as garment specification.

Surgical gowns accounted for 55.24% share of the North America hospital gowns market size in 2025, which kept this category in the leading position across type segments and reflected its mandatory use in every operating room encounter. Their position remains supported by the broad range of invasive procedures that still require reliable barrier protection, standardized classification, and dependable SKU availability across hospital and outpatient settings. Revenue concentration stays strongest in surgical gowns because these products carry higher performance requirements and often command more value per unit than basic non-surgical alternatives. At the same time, the expansion of outpatient case flow is extending operating-room-equivalent gown demand into a wider set of facilities that do not purchase in exactly the same way as large hospitals. This keeps surgical gowns at the center of competitive strategy in the North America hospital gowns market, particularly for suppliers with premium barrier portfolios and strong delivery performance.

Patient gowns are projected to grow at 9.52% CAGR through 2031, which makes them the fastest-moving type segment as outpatient admissions, longer patient stays in selected settings, and comfort-related procurement priorities gain weight. Non-surgical gowns still serve a broad daily care base across nursing, examination, and post-procedure use, but their lower unit values keep the category more exposed to budget tradeoffs. Medline's July 2025 launch of the ComfortTemp Patient Warming System showed how patient gown development is moving beyond basic coverage toward added clinical utility in perioperative care. That direction matters because providers are looking more closely at patient comfort, fit, and compliance when textile decisions affect both care experience and workflow efficiency. It also matters because premium patient gown formats can support broader care objectives without requiring the same barrier premium that defines surgical products. The patient gown opportunity is therefore expanding on both volume and design relevance, which gives suppliers space to differentiate in a category once treated as a simple commodity.

Complete Report Scope:

• By Usability
  • Disposable Gowns
  • Reusable Gowns
• By Type
  • Surgical Gowns
  • Non-Surgical Gowns
  • Patient Gowns
• By Risk Type
  • Minimal Risk Gowns
  • Low Risk Gowns
  • Moderate Risk Gowns
  • High Risk Gowns
• By End User
  • Hospitals and Clinics
  • Long-Term Care Facilities
  • Ambulatory Surgical Centers
  • Home Healthcare
• By Country
  • United States
  • Canada
  • Mexico

List of Companies Covered in this Report:

1. Solventum Corporation
2. Aramark
3. B. Braun
4. Cardinal Health
5. Dynarex
6. Encompass Group, LLC
7. Halyard Health, Inc.
8. Kimberly-Clark Worldwide
9. Lohmann and Rauscher GmbH and Co. KG
10. Medline Industries
11. Molnlycke Health Care
12. Owens and Minor, Inc.
13. Hartmann Group
14. PRIMED Medical Products Inc.
15. Standard Textile Co., Inc.
16. TIDI Products, LLC
17. Vestis Corporation

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Infection Control Mandates and Hospital-Acquired Infection Prevention
  • 4.2.2 Surgical Volume Growth and Procedural Throughput Requirements
  • 4.2.3 Rising Preference for Disposable Gowns in High-Turnover Care Settings
  • 4.2.4 Sustainability-Led Reusable Gown Procurement in Mature Health Systems
  • 4.2.5 Reusable Gown Laundering Validation and Closed-Loop Service Models
  • 4.2.6 Gown Performance Verification, Traceability, and Procurement Digitization
• 4.3 Market Restraints
  • 4.3.1 Premium Product Cost Pressure in Budget-Constrained Facilities
  • 4.3.2 Regulatory and Barrier-Performance Compliance Complexity
  • 4.3.3 Supply Chain Dependence on Nonwoven and Meltblown Inputs
  • 4.3.4 Operational Readiness Gaps for Reusable Gown Adoption
• 4.4 Supply Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry Analysis

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Usability
  • 5.1.1 Disposable Gowns
  • 5.1.2 Reusable Gowns
• 5.2 By Type
  • 5.2.1 Surgical Gowns
  • 5.2.2 Non-Surgical Gowns
  • 5.2.3 Patient Gowns
• 5.3 By Risk Type
  • 5.3.1 Minimal Risk Gowns
  • 5.3.2 Low Risk Gowns
  • 5.3.3 Moderate Risk Gowns
  • 5.3.4 High Risk Gowns
• 5.4 By End User
  • 5.4.1 Hospitals and Clinics
  • 5.4.2 Long-Term Care Facilities
  • 5.4.3 Ambulatory Surgical Centers
  • 5.4.4 Home Healthcare
• 5.5 By Country
  • 5.5.1 United States
  • 5.5.2 Canada
  • 5.5.3 Mexico

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.3.1 Solventum Corporation
  • 6.3.2 Aramark
  • 6.3.3 B. Braun Melsungen AG
  • 6.3.4 Cardinal Health, Inc.
  • 6.3.5 Dynarex Corporation
  • 6.3.6 Encompass Group, LLC
  • 6.3.7 Halyard Health, Inc.
  • 6.3.8 Kimberly-Clark Corporation
  • 6.3.9 Lohmann and Rauscher GmbH and Co. KG
  • 6.3.10 Medline Industries, LP
  • 6.3.11 Molnlycke Health Care AB
  • 6.3.12 Owens and Minor, Inc.
  • 6.3.13 Paul Hartmann AG
  • 6.3.14 PRIMED Medical Products Inc.
  • 6.3.15 Standard Textile Co., Inc.
  • 6.3.16 TIDI Products, LLC
  • 6.3.17 Vestis Corporation

7 Market Opportunities & Future Outlook

• 7.1 White-Space and Unmet-Need Assessment